Showing results (121-130 of 330) with videos related to

Sort By:
Pageof 33
Breast Cancer Research and Treatment|August 10, 2006
The combination of letrozole and trastuzumab as first or second-line biological therapy produces durable responses in a subset of HER2 positive and ER positive advanced breast cancersP Kelly Marcom, Claudine Isaacs, Lyndsay Harris, et al.
Cancer Biology & Therapy|March 17, 2004
Estrogen receptor expression and sensitivity to paclitaxel in breast cancerMichele K Dougherty, Lisa M Schumaker, V Craig Jordan, et al.
Breast Cancer Research and Treatment|October 23, 2008
Aromatase expression and outcomes in the P024 neoadjuvant endocrine therapy trialMatthew J Ellis, William R Miller, Yu Tao, et al.
AJR. American Journal of Roentgenology|January 23, 2016
Application of a Novel CT-Based Iliac Artery Calcification Scoring System for Predicting Renal Transplant OutcomesBradley Davis, Daniele Marin, Lynne M Hurwitz, et al.
Plos One|December 29, 2012
Application of a high throughput method of biomarker discovery to improvement of the EarlyCDT(®)-Lung TestIsabel K Macdonald, Andrea Murray, Graham F Healey, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 8, 2011
EarlyCDT-Lung: an immunobiomarker test as an aid to early detection of lung cancerStephen Lam, Peter Boyle, Graham F Healey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 8, 2011
Opposing effects of Runx2 and estradiol on breast cancer cell proliferation: in vitro identification of reciprocally regulated gene signature related to clinical letrozole responsivenessNyam-Osor Chimge, Sanjeev K Baniwal, Jingqin Luo, et al.
Clinical Proteomics|October 25, 2023
Mass spectrometry quantifies target engagement for a KRASG12C inhibitor in FFPE tumor tissueAndrew G Chambers, David C Chain, Steve M Sweet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 2022
Evaluation of Sensitivity to Endocrine Therapy Index (SET2,3) for Response to Neoadjuvant Endocrine Therapy and Longer-Term Breast Cancer Patient Outcomes (Alliance Z1031)Vera J Suman, Lili Du, Tanya Hoskin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2004
A pilot surrogate end point biomarker trial of perillyl alcohol in breast neoplasiaVered Stearns, Andrew Coop, Baljit Singh, et al.
Pageof 33